This suggests that the activation and release of IL-1b and  IL-18, mediated by excessive activation of Caspase-1 in PBMCs from SLE patients, contribute to the pathogenesis of SLE and LN. The gene discussed is IL1B; the disease is systemic lupus erythematosus.